Allosteric Inhibitors of HIPK2 for the Treatment of Renal Fibrosis

Description:

Thank you for your interest in this technology. Please see our technology brief here: https://app.in-part.com/articles/RQx7n6Ja7ZeM

Patent Information:
Category(s):
Therapeutic
For Information, Contact:
Nolan Skop
Manager, Business Development & Licensing
Icahn School of Medicine at Mount Sinai
nolan.skop@mssm.edu
Inventors:
John Cijiang He
Keywords:
Fibrosis
Nephrology
© 2024. All Rights Reserved. Powered by Inteum